FRANCISCO JAVIER
DOLCET ROCA
CON
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (5)
2016
-
2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371
2012
-
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
International Journal of Cancer, Vol. 130, Núm. 4, pp. 967-978
2009
-
Expression of somatostatin receptors in human melanoma cell lines: Effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation
Journal of International Medical Research, Vol. 37, Núm. 6, pp. 1813-1822
2008
-
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines
British Journal of Dermatology, Vol. 158, Núm. 3, pp. 496-504
2006
-
Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines
Melanoma Research, Vol. 16, Núm. 2, pp. 127-135